These are the results of seven days of once-daily oral administration of 500 mg Cravit given to 143 infectious respiratory disease patients. The efficacy rate was 95.1%. A once-daily administration of 500 mg Cravit contributed to the excellent clinical results in treating infectious respiratory disease.